IME Stock Overview
ImExHS Limited offers cloud-based medical imaging solutions in Australia and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
ImExHS Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.57 |
| 52 Week High | AU$0.70 |
| 52 Week Low | AU$0.52 |
| Beta | 1.24 |
| 1 Month Change | -5.00% |
| 3 Month Change | n/a |
| 1 Year Change | -3.39% |
| 3 Year Change | -75.74% |
| 5 Year Change | -64.38% |
| Change since IPO | -61.36% |
Recent News & Updates
Recent updates
Shareholder Returns
| IME | AU Healthcare Services | AU Market | |
|---|---|---|---|
| 7D | 2.7% | 0.9% | -1.5% |
| 1Y | -3.4% | 63.7% | 5.7% |
Return vs Industry: IME underperformed the Australian Healthcare Services industry which returned 63.7% over the past year.
Return vs Market: IME underperformed the Australian Market which returned 5.7% over the past year.
Price Volatility
| IME volatility | |
|---|---|
| IME Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 7.8% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 17.6% |
| 10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: IME has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine IME's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 400 | German Arango | www.imexhs.com |
ImExHS Limited offers cloud-based medical imaging solutions in Australia and internationally. It offers a medical imaging software that is focused on the development and sale of modular imaging systems, which include information systems for radiology, cardiology, and pathology, as well as a picture archiving and communications system. The company’s solutions include AQUILA, a radiology software solution; ALULA, a pathology software solution; Antero, a cardiology software solution; and STELLA AI, a set of artificial intelligence tools that support specialists in the diagnosis.
ImExHS Limited Fundamentals Summary
| IME fundamental statistics | |
|---|---|
| Market cap | AU$24.13m |
| Earnings (TTM) | -AU$4.19m |
| Revenue (TTM) | AU$19.89m |
1.2x
P/S Ratio-5.5x
P/E RatioIs IME overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IME income statement (TTM) | |
|---|---|
| Revenue | AU$19.89m |
| Cost of Revenue | AU$11.80m |
| Gross Profit | AU$8.09m |
| Other Expenses | AU$12.28m |
| Earnings | -AU$4.19m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.092 |
| Gross Margin | 40.68% |
| Net Profit Margin | -21.08% |
| Debt/Equity Ratio | 7.9% |
How did IME perform over the long term?
See historical performance and comparison